Page last updated: 2024-10-31

naftopidil and Injuries, Spinal Cord

naftopidil has been researched along with Injuries, Spinal Cord in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Naftopidil treatment reduced the upregulation of mRNA levels of ischemia and fibrosis markers at the early phase of SCI, and ameliorated the decrease of bladder compliance and voiding efficiency, and the increase of urethral pressure and collagen concentration in the bladder wall at the late phase of SCI."1.46Effects of an alpha1A/D-adrenoceptor antagonist, naftopidil, and a phosphodiesterase type 5 inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal cord injury. ( Kadekawa, K; Kawamorita, N; Majima, T; Mori, K; Okada, H; Sugaya, K; Tyagi, P; Yoshimura, N; Yoshizawa, T, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kadekawa, K2
Sugaya, K2
Nishijima, S1
Ashitomi, K1
Miyazato, M1
Ueda, T1
Yamamoto, H1
Majima, T1
Kawamorita, N1
Okada, H1
Yoshizawa, T1
Mori, K1
Tyagi, P1
Yoshimura, N1

Other Studies

2 other studies available for naftopidil and Injuries, Spinal Cord

ArticleYear
Effect of naftopidil, an alpha1D/A-adrenoceptor antagonist, on the urinary bladder in rats with spinal cord injury.
    Life sciences, 2013, May-30, Volume: 92, Issue:20-21

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Animals; Female; Naphthalenes; Piperazines; Rats

2013
Effects of an alpha1A/D-adrenoceptor antagonist, naftopidil, and a phosphodiesterase type 5 inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal cord injury.
    Neurourology and urodynamics, 2017, Volume: 36, Issue:6

    Topics: Adrenergic alpha-Antagonists; Animals; Female; Naphthalenes; Phosphodiesterase 5 Inhibitors; Piperaz

2017